Page 12 - பர்‌ட்யூ ஆராய்ச்சி அடித்தளம் அலுவலகம் ஆஃப் தொழில்நுட்பம் வணிகமயமாக்கல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பர்‌ட்யூ ஆராய்ச்சி அடித்தளம் அலுவலகம் ஆஃப் தொழில்நுட்பம் வணிகமயமாக்கல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பர்‌ட்யூ ஆராய்ச்சி அடித்தளம் அலுவலகம் ஆஃப் தொழில்நுட்பம் வணிகமயமாக்கல் Today - Breaking & Trending Today

All-in-one device uses microwave power for defense, medicine - The Paper of Montgomery County

An invention from Purdue University innovators may provide a new option to use directed energy for biomedical and defense applications.
The Purdue invention use ....

United States , Andrew Fairbanks , Matthew Halladay , Most Innovative University , Purdue University , Us Services , Energy Professional Society , Purdue Research Foundation Office Of Technology Commercialization , Purdue College Of Engineering , Ipwatchdog Institute , Association Of Public , Office Of Naval Research Grant No , Purdue Research Foundation , Technology Symposium , Convergence Center , Naval Research , Directed Energy Professional Society , Purdue Research Foundation Office , Technology Commercialization , Discovery Park District , Economic Prosperity Universities Award , Innovative University , World Report , ஒன்றுபட்டது மாநிலங்களில் , ஆண்ட்ரூ நியாயமான வங்கிகள் , மேத்யூ ஹாலடே ,

All-in-one device uses microwave power for defense, medicine

E-Mail
WEST LAFAYETTE, Ind. - An invention from Purdue University innovators may provide a new option to use directed energy for biomedical and defense applications.
The Purdue invention uses composite based nonlinear transmission lines (NLTLs) for a complete high-power microwave system, eliminating the need for multiple auxiliary systems. The interest in NLTLs has increased in the past few decades because they offer an effective solid-state alternative to conventional vacuum-based, high-power microwave generators that require large and expensive external systems, such as cryogenic electromagnets and high-voltage nanosecond pulse generators.
NLTLs have proven effective for applications in the defense and biomedical fields. They create directed high-power microwaves that can be used to disrupt or destroy adversary electronic equipment at a distance. The same technology also can be used for biomedical devices for sterilization and noninvasive medical treatments. ....

United States , Andrew Fairbanks , Chris Adam , Matthew Halladay , Most Innovative University , Purdue University , Us Services , Energy Professional Society , Purdue Research Foundation Office Of Technology Commercialization , Purdue College Of Engineering , Ipwatchdog Institute , Association Of Public , Office Of Naval Research Grant No , Purdue Research Foundation , Technology Symposium , Convergence Center , Naval Research , Directed Energy Professional Society , Purdue Research Foundation Office , Technology Commercialization , Discovery Park District , Economic Prosperity Universities Award , Innovative University , World Report , ஒன்றுபட்டது மாநிலங்களில் , ஆண்ட்ரூ நியாயமான வங்கிகள் ,

Neuroscience seminar highlights technologies for brain injuries, vaccine developments

Neuroscience seminar highlights technologies for brain injuries, vaccine developments
The Purdue Center for Paralysis Research brings neurophysiological and engineering solutions to a trauma-themed seminar series, co-sponsored by Plexon. (Image provided)
WEST LAFAYETTE, Ind. – The same technology that helps treat traumatic brain injuries in athletes and soldiers may one day help doctors determine the effectiveness of vaccines on patients.
This technology is among the neuroscience innovations and research in the spotlight as Purdue University’s Center for Paralysis Research and Plexon Neurotechnology Systems present the Seminar for Neurotrauma and Diseases. The seminar series, which runs through April, features speakers from Purdue, Harvard Medical School and the medical industry. ....

United States , Riyi Shi , Purdue Mari Hulman George , Chris Adam , Andrew Klein , Most Innovative University , Purdue University , Purdue Research Foundation Office Of Technology Commercialization , Purdue University Center , Purdue Institute For Integrative Neuroscience , Harvard Medical School , Paralysis Research , Purdue University College Of Veterinary Medicine , Purdue Research Foundation , Purdue Center , Purdue Institute For Drug Discovery , College Of Veterinary Medicine , Plexon Neurotechnology Systems , Purdue Mari Hulman George Endowed Professor , Applied Neuroscience , Veterinary Medicine , Purdue Institute , Integrative Neuroscience , World War , Purdue Research Foundation Office , Purdue University College ,

New inhibitors may offer novel approach to treating deadly tuberculosis

New inhibitors may offer novel approach to treating deadly tuberculosis
Zhong-Yin Zhang, head of Purdue’s Department of Medicinal Chemistry and Molecular Pharmacology, developed highly potent and selective compounds for use in the treatment of tuberculosis. (Image provided)
WEST LAFAYETTE, Ind. – Purdue University innovators have developed highly potent and selective compounds for use in the treatment of tuberculosis, which is one of the top 10 causes of death worldwide.
The Purdue researchers developed a series of small molecule inhibitors to target one of the proteins critical for the survival of TB in infected macrophages. Protein tyrosine phosphates B (mPTPB) is a virulence factor of TB to subvert the host immune responses. ....

United States , Joseph Kasper , Chris Adam , Most Innovative University , Purdue University , Us Services , Purdue Research Foundation Office Of Technology Commercialization , Purdue Department Of Medicinal Chemistry , Ipwatchdog Institute , Purdue Research Foundationoffice Of Technology Commercializationto , Association Of Public , Purdue Research Foundation , Purdue Institute For Drug Discovery , Convergence Center , Zhong Yin Zhang , Medicinal Chemistry , Molecular Pharmacology , Purdue Institute , Purdue Research Foundation Office , Technology Commercializationto , Technology Commercialization , Discovery Park District , Economic Prosperity Universities Award , Innovative University , World Report , ஒன்றுபட்டது மாநிலங்களில் ,

Inhibitors may offer approach to treating tuberculosis

Listen to this article
WEST LAFAYETTE, Ind. â Purdue University innovators have developed highly potent and selective compounds for use in the treatment of tuberculosis, which is one of the top 10 causes of death worldwide.
The Purdue researchers developed a series of small molecule inhibitors to target one of the proteins critical for the survival of TB in infected macrophages. Protein tyrosine phosphates B (mPTPB) is a virulence factor of TB to subvert the host immune responses.
The Purdue research is published in the Journal of Medicinal Chemistry.
âThe death toll from TB is particularly high because of drug-resistant strains,â said Zhong-Yin Zhang, distinguished professor and head of Purdueâs Department of Medicinal Chemistry and Molecular Pharmacology and director of Purdue Institute for Drug Discovery. âThese inhibitors are part of a promising new approach to developing TB therapeutic agents with novel targets and mechanisms of actio ....

Purdue University , Purdue Institute For Drug Discovery , Purdue Research Foundation Office Of Technology Commercialization , Purdue Department Of Medicinal Chemistry , Zhong Yin Zhang , Medicinal Chemistry , Molecular Pharmacology , Purdue Institute , Purdue Research Foundation Office , Technology Commercialization , பர்‌ட்யூ பல்கலைக்கழகம் , பர்‌ட்யூ நிறுவனம் க்கு மருந்து கண்டுபிடிப்பு , பர்‌ட்யூ ஆராய்ச்சி அடித்தளம் அலுவலகம் ஆஃப் தொழில்நுட்பம் வணிகமயமாக்கல் , பர்‌ட்யூ துறை ஆஃப் மருத்துவ வேதியியல் , ஜாங் யின் ஜாங் , மருத்துவ வேதியியல் , மூலக்கூறு மருந்தியல் , பர்‌ட்யூ நிறுவனம் , பர்‌ட்யூ ஆராய்ச்சி அடித்தளம் அலுவலகம் , தொழில்நுட்பம் வணிகமயமாக்கல் ,